Home › Funds › Hikari Tsushin, Inc. › SOLV

Hikari Tsushin, Inc. position in SOLV

SOLVENTUM CORP · Health Care

Hikari Tsushin, Inc. reported holding 21,397 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.13% of its reported portfolio and ranking #41 among its reported holdings. Hikari Tsushin, Inc. has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)21.40K sh
Reported value held$1.89M
Portfolio Weight0.13%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hikari Tsushin, Inc.'s SOLV position evolved

Hikari Tsushin, Inc. first disclosed a stake in SOLV in Q2 2024 at 56,180 shares (US$3.0M). The position peaked in Q4 2025 at 56,180 shares, worth US$4.5M. Across 10 filings, Hikari Tsushin, Inc. increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 21,397 shares valued at US$1.9M — a reduction of -13,823 shares quarter over quarter.. Notable position changes include a 34% trim in Q2 2026 (shares rose 14% over the following quarter), a 39% trim in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 56.18K $2.97M New
Q3 2024 56.18K $3.92M Hold
Q4 2024 56.18K $3.71M Hold
Q1 2025 56.18K $4.27M Hold
Q2 2025 56.18K $4.26M Hold
Q3 2025 56.18K $4.10M Hold
Q4 2025 56.18K $4.45M Hold
Q1 2026 53.11K $3.47M Reduce
Q2 2026 35.22K $2.72M Reduce
Q3 2026 21.40K $1.89M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has Hikari Tsushin, Inc. held SOLV?

Hikari Tsushin, Inc. has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Hikari Tsushin, Inc.'s current position in SOLV?

As of Q3 2026, Hikari Tsushin, Inc. holds 21.40K shares of SOLV (SOLVENTUM CORP), valued at $1.89M, representing 0.13% of its reported portfolio and ranking #41.

Has Hikari Tsushin, Inc. been buying or selling SOLV?

In the latest 13F filing (Q3 2026), Hikari Tsushin, Inc. reduced its position in SOLV. The position peaked in Q4 2025 at 56.18K shares.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.